The global market for Pd-1 and Pd-L1 Inhibitors was estimated to be worth US$ 39550 million in 2023 and is forecast to a readjusted size of US$ 64130 million by 2030 with a CAGR of 7.0% during the forecast period 2024-2030

Pd-1 and Pd-L1 Inhibitors - Market

PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitors being developed for the treatment of cancer. PD-1 and PD-L1 are both proteins present on the surface of cells. Immune checkpoint inhibitors such as these are emerging as a front-line treatment for several types of cancer.

North America is the largest consumption place, with a consumption market share nearly 60.40% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 20.66%.Market competition is intense. Merck, Bristol-Myers Squibb, Roche, AstraZeneca, Ono Pharmaceutical etc. are the leaders of the industry.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pd-1 and Pd-L1 Inhibitors, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pd-1 and Pd-L1 Inhibitors by region & country, by Type, and by Application.

The Pd-1 and Pd-L1 Inhibitors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pd-1 and Pd-L1 Inhibitors.

Market Segmentation

Scope of Pd-1 and Pd-L1 Inhibitors - Market Report

Report Metric	Details
Report Name	Pd-1 and Pd-L1 Inhibitors - Market
Forecasted market size in 2030	US$ 64130 million
CAGR	7.0%
Forecasted years	2024 - 2030
Segment by Type:	PD-1 PD-L1
Segment by Application	Hospital Pharmacies Retail Pharmacies Specialty Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bristol-Myers Squibb, Merck, F. Hoffmann-La Roche, Sanofi, Amgen, Gilead Sciences, AstraZeneca, Novartis, Pfizer, Celgene
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pd-1 and Pd-L1 Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Pd-1 and Pd-L1 Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Pd-1 and Pd-L1 Inhibitors in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Pd-1 and Pd-L1 Inhibitors - Market size in 2030?

Ans: The Pd-1 and Pd-L1 Inhibitors - Market size in 2030 will be US$ 64130 million.

Who are the main players in the Pd-1 and Pd-L1 Inhibitors - Market report?

Ans: The main players in the Pd-1 and Pd-L1 Inhibitors - Market are Bristol-Myers Squibb, Merck, F. Hoffmann-La Roche, Sanofi, Amgen, Gilead Sciences, AstraZeneca, Novartis, Pfizer, Celgene

What are the Application segmentation covered in the Pd-1 and Pd-L1 Inhibitors - Market report?

Ans: The Applications covered in the Pd-1 and Pd-L1 Inhibitors - Market report are Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies

What are the Type segmentation covered in the Pd-1 and Pd-L1 Inhibitors - Market report?

Ans: The Types covered in the Pd-1 and Pd-L1 Inhibitors - Market report are PD-1, PD-L1

1 Market Overview

1.1 Pd-1 and Pd-L1 Inhibitors Product Introduction

1.2 Global Pd-1 and Pd-L1 Inhibitors Market Size Forecast

1.2.1 Global Pd-1 and Pd-L1 Inhibitors Sales Value (2019-2030)

1.2.2 Global Pd-1 and Pd-L1 Inhibitors Sales Volume (2019-2030)

1.2.3 Global Pd-1 and Pd-L1 Inhibitors Sales Price (2019-2030)

1.3 Pd-1 and Pd-L1 Inhibitors Market Trends & Drivers

1.3.1 Pd-1 and Pd-L1 Inhibitors Industry Trends

1.3.2 Pd-1 and Pd-L1 Inhibitors Market Drivers & Opportunity

1.3.3 Pd-1 and Pd-L1 Inhibitors Market Challenges

1.3.4 Pd-1 and Pd-L1 Inhibitors Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Pd-1 and Pd-L1 Inhibitors Players Revenue Ranking (2023)

2.2 Global Pd-1 and Pd-L1 Inhibitors Revenue by Company (2019-2024)

2.3 Global Pd-1 and Pd-L1 Inhibitors Players Sales Volume Ranking (2023)

2.4 Global Pd-1 and Pd-L1 Inhibitors Sales Volume by Company Players (2019-2024)

2.5 Global Pd-1 and Pd-L1 Inhibitors Average Price by Company (2019-2024)

2.6 Key Manufacturers Pd-1 and Pd-L1 Inhibitors Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Pd-1 and Pd-L1 Inhibitors Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Pd-1 and Pd-L1 Inhibitors

2.9 Pd-1 and Pd-L1 Inhibitors Market Competitive Analysis

2.9.1 Pd-1 and Pd-L1 Inhibitors Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Pd-1 and Pd-L1 Inhibitors Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pd-1 and Pd-L1 Inhibitors as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 PD-1

3.1.2 PD-L1

3.2 Global Pd-1 and Pd-L1 Inhibitors Sales Value by Type

3.2.1 Global Pd-1 and Pd-L1 Inhibitors Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Pd-1 and Pd-L1 Inhibitors Sales Value, by Type (2019-2030)

3.2.3 Global Pd-1 and Pd-L1 Inhibitors Sales Value, by Type (%) (2019-2030)

3.3 Global Pd-1 and Pd-L1 Inhibitors Sales Volume by Type

3.3.1 Global Pd-1 and Pd-L1 Inhibitors Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Pd-1 and Pd-L1 Inhibitors Sales Volume, by Type (2019-2030)

3.3.3 Global Pd-1 and Pd-L1 Inhibitors Sales Volume, by Type (%) (2019-2030)

3.4 Global Pd-1 and Pd-L1 Inhibitors Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital Pharmacies

4.1.2 Retail Pharmacies

4.1.3 Specialty Pharmacies

4.2 Global Pd-1 and Pd-L1 Inhibitors Sales Value by Application

4.2.1 Global Pd-1 and Pd-L1 Inhibitors Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Pd-1 and Pd-L1 Inhibitors Sales Value, by Application (2019-2030)

4.2.3 Global Pd-1 and Pd-L1 Inhibitors Sales Value, by Application (%) (2019-2030)

4.3 Global Pd-1 and Pd-L1 Inhibitors Sales Volume by Application

4.3.1 Global Pd-1 and Pd-L1 Inhibitors Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Pd-1 and Pd-L1 Inhibitors Sales Volume, by Application (2019-2030)

4.3.3 Global Pd-1 and Pd-L1 Inhibitors Sales Volume, by Application (%) (2019-2030)

4.4 Global Pd-1 and Pd-L1 Inhibitors Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Pd-1 and Pd-L1 Inhibitors Sales Value by Region

5.1.1 Global Pd-1 and Pd-L1 Inhibitors Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Pd-1 and Pd-L1 Inhibitors Sales Value by Region (2019-2024)

5.1.3 Global Pd-1 and Pd-L1 Inhibitors Sales Value by Region (2025-2030)

5.1.4 Global Pd-1 and Pd-L1 Inhibitors Sales Value by Region (%), (2019-2030)

5.2 Global Pd-1 and Pd-L1 Inhibitors Sales Volume by Region

5.2.1 Global Pd-1 and Pd-L1 Inhibitors Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Pd-1 and Pd-L1 Inhibitors Sales Volume by Region (2019-2024)

5.2.3 Global Pd-1 and Pd-L1 Inhibitors Sales Volume by Region (2025-2030)

5.2.4 Global Pd-1 and Pd-L1 Inhibitors Sales Volume by Region (%), (2019-2030)

5.3 Global Pd-1 and Pd-L1 Inhibitors Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Pd-1 and Pd-L1 Inhibitors Sales Value, 2019-2030

5.4.2 North America Pd-1 and Pd-L1 Inhibitors Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Pd-1 and Pd-L1 Inhibitors Sales Value, 2019-2030

5.5.2 Europe Pd-1 and Pd-L1 Inhibitors Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Pd-1 and Pd-L1 Inhibitors Sales Value, 2019-2030

5.6.2 Asia Pacific Pd-1 and Pd-L1 Inhibitors Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Pd-1 and Pd-L1 Inhibitors Sales Value, 2019-2030

5.7.2 South America Pd-1 and Pd-L1 Inhibitors Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales Value, 2019-2030

5.8.2 Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Pd-1 and Pd-L1 Inhibitors Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Pd-1 and Pd-L1 Inhibitors Sales Value

6.2.1 Key Countries/Regions Pd-1 and Pd-L1 Inhibitors Sales Value, 2019-2030

6.2.2 Key Countries/Regions Pd-1 and Pd-L1 Inhibitors Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Pd-1 and Pd-L1 Inhibitors Sales Value, 2019-2030

6.3.2 United States Pd-1 and Pd-L1 Inhibitors Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Pd-1 and Pd-L1 Inhibitors Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Pd-1 and Pd-L1 Inhibitors Sales Value, 2019-2030

6.4.2 Europe Pd-1 and Pd-L1 Inhibitors Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Pd-1 and Pd-L1 Inhibitors Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Pd-1 and Pd-L1 Inhibitors Sales Value, 2019-2030

6.5.2 China Pd-1 and Pd-L1 Inhibitors Sales Value by Type (%), 2023 VS 2030

6.5.3 China Pd-1 and Pd-L1 Inhibitors Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Pd-1 and Pd-L1 Inhibitors Sales Value, 2019-2030

6.6.2 Japan Pd-1 and Pd-L1 Inhibitors Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Pd-1 and Pd-L1 Inhibitors Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Pd-1 and Pd-L1 Inhibitors Sales Value, 2019-2030

6.7.2 South Korea Pd-1 and Pd-L1 Inhibitors Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Pd-1 and Pd-L1 Inhibitors Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Pd-1 and Pd-L1 Inhibitors Sales Value, 2019-2030

6.8.2 Southeast Asia Pd-1 and Pd-L1 Inhibitors Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Pd-1 and Pd-L1 Inhibitors Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Pd-1 and Pd-L1 Inhibitors Sales Value, 2019-2030

6.9.2 India Pd-1 and Pd-L1 Inhibitors Sales Value by Type (%), 2023 VS 2030

6.9.3 India Pd-1 and Pd-L1 Inhibitors Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Bristol-Myers Squibb

7.1.1 Bristol-Myers Squibb Company Information

7.1.2 Bristol-Myers Squibb Introduction and Business Overview

7.1.3 Bristol-Myers Squibb Pd-1 and Pd-L1 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Bristol-Myers Squibb Pd-1 and Pd-L1 Inhibitors Product Offerings

7.1.5 Bristol-Myers Squibb Recent Development

7.2 Merck

7.2.1 Merck Company Information

7.2.2 Merck Introduction and Business Overview

7.2.3 Merck Pd-1 and Pd-L1 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Merck Pd-1 and Pd-L1 Inhibitors Product Offerings

7.2.5 Merck Recent Development

7.3 F. Hoffmann-La Roche

7.3.1 F. Hoffmann-La Roche Company Information

7.3.2 F. Hoffmann-La Roche Introduction and Business Overview

7.3.3 F. Hoffmann-La Roche Pd-1 and Pd-L1 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

7.3.4 F. Hoffmann-La Roche Pd-1 and Pd-L1 Inhibitors Product Offerings

7.3.5 F. Hoffmann-La Roche Recent Development

7.4 Sanofi

7.4.1 Sanofi Company Information

7.4.2 Sanofi Introduction and Business Overview

7.4.3 Sanofi Pd-1 and Pd-L1 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Sanofi Pd-1 and Pd-L1 Inhibitors Product Offerings

7.4.5 Sanofi Recent Development

7.5 Amgen

7.5.1 Amgen Company Information

7.5.2 Amgen Introduction and Business Overview

7.5.3 Amgen Pd-1 and Pd-L1 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Amgen Pd-1 and Pd-L1 Inhibitors Product Offerings

7.5.5 Amgen Recent Development

7.6 Gilead Sciences

7.6.1 Gilead Sciences Company Information

7.6.2 Gilead Sciences Introduction and Business Overview

7.6.3 Gilead Sciences Pd-1 and Pd-L1 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Gilead Sciences Pd-1 and Pd-L1 Inhibitors Product Offerings

7.6.5 Gilead Sciences Recent Development

7.7 AstraZeneca

7.7.1 AstraZeneca Company Information

7.7.2 AstraZeneca Introduction and Business Overview

7.7.3 AstraZeneca Pd-1 and Pd-L1 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

7.7.4 AstraZeneca Pd-1 and Pd-L1 Inhibitors Product Offerings

7.7.5 AstraZeneca Recent Development

7.8 Novartis

7.8.1 Novartis Company Information

7.8.2 Novartis Introduction and Business Overview

7.8.3 Novartis Pd-1 and Pd-L1 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Novartis Pd-1 and Pd-L1 Inhibitors Product Offerings

7.8.5 Novartis Recent Development

7.9 Pfizer

7.9.1 Pfizer Company Information

7.9.2 Pfizer Introduction and Business Overview

7.9.3 Pfizer Pd-1 and Pd-L1 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Pfizer Pd-1 and Pd-L1 Inhibitors Product Offerings

7.9.5 Pfizer Recent Development

7.10 Celgene

7.10.1 Celgene Company Information

7.10.2 Celgene Introduction and Business Overview

7.10.3 Celgene Pd-1 and Pd-L1 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Celgene Pd-1 and Pd-L1 Inhibitors Product Offerings

7.10.5 Celgene Recent Development

8 Industry Chain Analysis

8.1 Pd-1 and Pd-L1 Inhibitors Industrial Chain

8.2 Pd-1 and Pd-L1 Inhibitors Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Pd-1 and Pd-L1 Inhibitors Sales Model

8.5.2 Sales Channel

8.5.3 Pd-1 and Pd-L1 Inhibitors Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Pd-1 and Pd-L1 Inhibitors Market Trends

Table 2. Pd-1 and Pd-L1 Inhibitors Market Drivers & Opportunity

Table 3. Pd-1 and Pd-L1 Inhibitors Market Challenges

Table 4. Pd-1 and Pd-L1 Inhibitors Market Restraints

Table 5. Global Pd-1 and Pd-L1 Inhibitors Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Company (2019-2024)

Table 7. Global Pd-1 and Pd-L1 Inhibitors Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Pd-1 and Pd-L1 Inhibitors Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Pd-1 and Pd-L1 Inhibitors Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Pd-1 and Pd-L1 Inhibitors Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Pd-1 and Pd-L1 Inhibitors Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Pd-1 and Pd-L1 Inhibitors

Table 13. Global Pd-1 and Pd-L1 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pd-1 and Pd-L1 Inhibitors as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Pd-1 and Pd-L1 Inhibitors Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Pd-1 and Pd-L1 Inhibitors Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Pd-1 and Pd-L1 Inhibitors Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Pd-1 and Pd-L1 Inhibitors Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Pd-1 and Pd-L1 Inhibitors Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Pd-1 and Pd-L1 Inhibitors Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Pd-1 and Pd-L1 Inhibitors Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Pd-1 and Pd-L1 Inhibitors Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Pd-1 and Pd-L1 Inhibitors Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Pd-1 and Pd-L1 Inhibitors Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Pd-1 and Pd-L1 Inhibitors Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Pd-1 and Pd-L1 Inhibitors Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Pd-1 and Pd-L1 Inhibitors Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Pd-1 and Pd-L1 Inhibitors Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Pd-1 and Pd-L1 Inhibitors Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Pd-1 and Pd-L1 Inhibitors Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Pd-1 and Pd-L1 Inhibitors Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Pd-1 and Pd-L1 Inhibitors Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Pd-1 and Pd-L1 Inhibitors Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Pd-1 and Pd-L1 Inhibitors Sales Value by Region (2019-2024) & (%)

Table 44. Global Pd-1 and Pd-L1 Inhibitors Sales Value by Region (2025-2030) & (%)

Table 45. Global Pd-1 and Pd-L1 Inhibitors Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Pd-1 and Pd-L1 Inhibitors Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Pd-1 and Pd-L1 Inhibitors Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Pd-1 and Pd-L1 Inhibitors Sales Volume by Region (2019-2024) & (%)

Table 49. Global Pd-1 and Pd-L1 Inhibitors Sales Volume by Region (2025-2030) & (%)

Table 50. Global Pd-1 and Pd-L1 Inhibitors Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Pd-1 and Pd-L1 Inhibitors Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Pd-1 and Pd-L1 Inhibitors Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Pd-1 and Pd-L1 Inhibitors Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Pd-1 and Pd-L1 Inhibitors Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Pd-1 and Pd-L1 Inhibitors Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Pd-1 and Pd-L1 Inhibitors Sales Volume, (2025-2030) & (K Units)

Table 57. Bristol-Myers Squibb Company Information

Table 58. Bristol-Myers Squibb Introduction and Business Overview

Table 59. Bristol-Myers Squibb Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Bristol-Myers Squibb Pd-1 and Pd-L1 Inhibitors Product Offerings

Table 61. Bristol-Myers Squibb Recent Development

Table 62. Merck Company Information

Table 63. Merck Introduction and Business Overview

Table 64. Merck Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Merck Pd-1 and Pd-L1 Inhibitors Product Offerings

Table 66. Merck Recent Development

Table 67. F. Hoffmann-La Roche Company Information

Table 68. F. Hoffmann-La Roche Introduction and Business Overview

Table 69. F. Hoffmann-La Roche Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. F. Hoffmann-La Roche Pd-1 and Pd-L1 Inhibitors Product Offerings

Table 71. F. Hoffmann-La Roche Recent Development

Table 72. Sanofi Company Information

Table 73. Sanofi Introduction and Business Overview

Table 74. Sanofi Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Sanofi Pd-1 and Pd-L1 Inhibitors Product Offerings

Table 76. Sanofi Recent Development

Table 77. Amgen Company Information

Table 78. Amgen Introduction and Business Overview

Table 79. Amgen Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Amgen Pd-1 and Pd-L1 Inhibitors Product Offerings

Table 81. Amgen Recent Development

Table 82. Gilead Sciences Company Information

Table 83. Gilead Sciences Introduction and Business Overview

Table 84. Gilead Sciences Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Gilead Sciences Pd-1 and Pd-L1 Inhibitors Product Offerings

Table 86. Gilead Sciences Recent Development

Table 87. AstraZeneca Company Information

Table 88. AstraZeneca Introduction and Business Overview

Table 89. AstraZeneca Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. AstraZeneca Pd-1 and Pd-L1 Inhibitors Product Offerings

Table 91. AstraZeneca Recent Development

Table 92. Novartis Company Information

Table 93. Novartis Introduction and Business Overview

Table 94. Novartis Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Novartis Pd-1 and Pd-L1 Inhibitors Product Offerings

Table 96. Novartis Recent Development

Table 97. Pfizer Company Information

Table 98. Pfizer Introduction and Business Overview

Table 99. Pfizer Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Pfizer Pd-1 and Pd-L1 Inhibitors Product Offerings

Table 101. Pfizer Recent Development

Table 102. Celgene Company Information

Table 103. Celgene Introduction and Business Overview

Table 104. Celgene Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Celgene Pd-1 and Pd-L1 Inhibitors Product Offerings

Table 106. Celgene Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Pd-1 and Pd-L1 Inhibitors Downstream Customers

Table 110. Pd-1 and Pd-L1 Inhibitors Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Pd-1 and Pd-L1 Inhibitors Product Picture

Figure 2. Global Pd-1 and Pd-L1 Inhibitors Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Pd-1 and Pd-L1 Inhibitors Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Pd-1 and Pd-L1 Inhibitors Sales Volume (2019-2030) & (K Units)

Figure 5. Global Pd-1 and Pd-L1 Inhibitors Sales Price (2019-2030) & (US$/Unit)

Figure 6. Pd-1 and Pd-L1 Inhibitors Report Years Considered

Figure 7. Global Pd-1 and Pd-L1 Inhibitors Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Pd-1 and Pd-L1 Inhibitors Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Pd-1 and Pd-L1 Inhibitors Revenue in 2023

Figure 10. Pd-1 and Pd-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. PD-1 Picture

Figure 12. PD-L1 Picture

Figure 13. Global Pd-1 and Pd-L1 Inhibitors Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Pd-1 and Pd-L1 Inhibitors Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Pd-1 and Pd-L1 Inhibitors Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Pd-1 and Pd-L1 Inhibitors Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Pd-1 and Pd-L1 Inhibitors Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Hospital Pharmacies

Figure 19. Product Picture of Retail Pharmacies

Figure 20. Product Picture of Specialty Pharmacies

Figure 21. Global Pd-1 and Pd-L1 Inhibitors Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Pd-1 and Pd-L1 Inhibitors Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Pd-1 and Pd-L1 Inhibitors Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Pd-1 and Pd-L1 Inhibitors Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Pd-1 and Pd-L1 Inhibitors Price by Application (2019-2030) & (US$/Unit)

Figure 26. North America Pd-1 and Pd-L1 Inhibitors Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Pd-1 and Pd-L1 Inhibitors Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Pd-1 and Pd-L1 Inhibitors Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Pd-1 and Pd-L1 Inhibitors Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Pd-1 and Pd-L1 Inhibitors Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Pd-1 and Pd-L1 Inhibitors Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Pd-1 and Pd-L1 Inhibitors Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Pd-1 and Pd-L1 Inhibitors Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Pd-1 and Pd-L1 Inhibitors Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Pd-1 and Pd-L1 Inhibitors Sales Volume (%), (2019-2030)

Figure 38. United States Pd-1 and Pd-L1 Inhibitors Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Pd-1 and Pd-L1 Inhibitors Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Pd-1 and Pd-L1 Inhibitors Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Pd-1 and Pd-L1 Inhibitors Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Pd-1 and Pd-L1 Inhibitors Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Pd-1 and Pd-L1 Inhibitors Sales Value by Application (%), 2023 VS 2030

Figure 44. China Pd-1 and Pd-L1 Inhibitors Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Pd-1 and Pd-L1 Inhibitors Sales Value by Type (%), 2023 VS 2030

Figure 46. China Pd-1 and Pd-L1 Inhibitors Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Pd-1 and Pd-L1 Inhibitors Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Pd-1 and Pd-L1 Inhibitors Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Pd-1 and Pd-L1 Inhibitors Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Pd-1 and Pd-L1 Inhibitors Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Pd-1 and Pd-L1 Inhibitors Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Pd-1 and Pd-L1 Inhibitors Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Pd-1 and Pd-L1 Inhibitors Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Pd-1 and Pd-L1 Inhibitors Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Pd-1 and Pd-L1 Inhibitors Sales Value by Application (%), 2023 VS 2030

Figure 56. India Pd-1 and Pd-L1 Inhibitors Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Pd-1 and Pd-L1 Inhibitors Sales Value by Type (%), 2023 VS 2030

Figure 58. India Pd-1 and Pd-L1 Inhibitors Sales Value by Application (%), 2023 VS 2030

Figure 59. Pd-1 and Pd-L1 Inhibitors Industrial Chain

Figure 60. Pd-1 and Pd-L1 Inhibitors Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions